Eli Lilly's new shot shows solid weight loss in study

TL;DR

Stock market fell as oil prices climbed due to geopolitical tensions.
Eli Lilly's retatrutide showed superior weight loss in type 2 diabetes study compared to Mounjaro.
Jim Cramer reiterated his 'own, don't trade' stance on Nvidia, linking its potential to Sandisk's performance.
Stocks discussed in the rapid fire segment included Five Below, Nucor, Darden Restaurants, Align Technology, and Uber.
The CNBC Investing Club provides trade alerts to subscribers, with specific waiting periods before executing trades.

Weiter zum Originalartikel